×
戻る Agenda
LS51 Next-Generation Digital Healthcare Considering Pre-Symptomatic State, Prevention, and Well-Being (Part 2)
Session Chair(s)
Takashi Moriya, PHD, MBA
Research Fellow, Keio University, KBS (Keio Business School) Graduate School, Japan
Speaker(s)
Takeru Hiki
CEO, Welby Inc, Japan
Hiroyuki Idone
Digital Health Program Lead, Novo Nordisk Pharma Ltd., Japan